A recent NIA-funded study found that nearly 40% of participants had brain changes associated with limbic-predominant age-related TDP-43 encephalopathy (LATE). LATE is a recently characterized brain disorder that causes symptoms similar to Alzheimer’s disease but with different underlying causes. There is currently no way to diagnose LATE in living people. In this study, a team […]
Researchers at the RUSH Alzheimer’s Disease Center have been awarded a half million dollars in funding from the National Institute on Aging to help study a portable device aimed at providing emotional comfort to people with Alzheimer’s disease and Alzheimer’s disease-related dementias. The device, Memesto, allows caregivers, family and friends to record and schedule music
RUSH Researchers Receive Grant to Study Dementia Therapy Device Read More »
Interested in volunteering for research on Alzheimer’s, related dementias, and cognitive health? Learn about new and featured studies below or search for clinical trials and studies near you with the Alzheimers.gov Clinical Trials Finder New and featured studies Click on the trial name for details and contact information. Caregiving Cognitive Training and Exercise Drugs Speech
Volunteers Needed for Studies to Advance Dementia Research Read More »
Recent funding opportunities and notices This alert links to all of the Funding Opportunity Announcements and Notices published by the National Institute on Aging at NIH in the previous month, giving researchers and trainees a heads up about what’s new. Read about the latest NIA Funding Opportunities (published in June 2022) by clicking on the
New funding opportunities from NIA Read More »
Interested in volunteering for research on Alzheimer’s disease, related dementias, and cognitive health? Learn about new and featured studies below or search for clinical trials and studies near you with the Alzheimers.gov Clinical Trials Finder. New and featured studies Click on the trial name for details and contact information. Caregiving SilverBills: A Financial and Legal Tech Tool
Volunteers Needed for Studies to Advance Dementia Research Read More »
Check out the latest in aging advances, research, and events from NIA: NIA statement on CMS Medicare coverage policy for approved monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s — Read a statement from NIA Director Richard J. Hodes, M.D. Blocking hormone improves Alzheimer’s symptoms in mice — An NIA-supported study found that a hormone
An NIA-supported study found that undergoing cataract removal was associated with a lower risk of developing dementia among older adults. Researchers analyzed data from a subset of participants from the Adult Changes in Thought (ACT) study. Participants were 65 years or older, dementia-free at the start of the study, and diagnosed with cataracts before the
Cataract Removal Linked to a Reduction in Dementia Risk Read More »
Black participants in Alzheimer’s disease research studies were 35% less likely to be diagnosed with Alzheimer’s and related dementias than white participants, despite national statistics that indicate that Black Americans are overall about twice as likely to develop dementias than whites. The analysis of data on study participants from across NIA’s network of Alzheimer’s Disease Research
Increasing African-American participation in medical research is challenging for a number of understandable and well-documented reasons. In part, many African Americans may mistrust medical research and the medical establishment based on past abuses, such as the infamous Tuskegee Syphilis Study. However, several NIA-supported Alzheimer’s Disease Center (ADC) researchers, in collaboration with members of their local African-American communities,
Fostering Alzheimer’s Brain Donation Among African Americans Read More »
